EAGLE Trial CADDIE Artificial Intelligence Endoscopy

NCT ID: NCT05730192

Last Updated: 2024-07-03

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

985 participants

Study Classification

INTERVENTIONAL

Study Start Date

2023-05-10

Study Completion Date

2023-11-29

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The EAGLE study is a prospective randomized controlled multicenter parallel design trial, for the assessment of clinical performance of the CADDIE device and to confirm that the device performs as expected.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The EAGLE study will be conducted with a parallel design. Patients who meet the study inclusion/exclusion criteria will be randomized in a 1:1 ratio to receive either computer-aided colonoscopy (CADDIE Arm) using CADDIE or standard colonoscopy without CADe (Control Arm). All resected polyps will be submitted for histologic examination.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Colorectal Cancer Polyp of Colon Adenoma Colon

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Parallel trial design
Primary Study Purpose

DIAGNOSTIC

Blinding Strategy

SINGLE

Outcome Assessors
Histology of the polyps is performed by the pathologist blinded to the study group assignment.

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

CADDIE colonoscopy (CADDIE Arm)

CADDIE is a computer-assisted detection (CADe) device used in conjunction with endoscopy for the detection of abnormal lesions in the gastrointestinal tract.

Group Type EXPERIMENTAL

CADDIE

Intervention Type DEVICE

A colonoscopy is an examination of the bowels using a colonoscope, or a thin, flexible tube with a light and camera. It can help identify issues like colorectal cancer, polyps, and ulcers.

Standard high-definition white light colonoscopy (Control Arm)

Patients will receive a standard colonoscopy

Group Type ACTIVE_COMPARATOR

CADDIE

Intervention Type DEVICE

A colonoscopy is an examination of the bowels using a colonoscope, or a thin, flexible tube with a light and camera. It can help identify issues like colorectal cancer, polyps, and ulcers.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

CADDIE

A colonoscopy is an examination of the bowels using a colonoscope, or a thin, flexible tube with a light and camera. It can help identify issues like colorectal cancer, polyps, and ulcers.

Intervention Type DEVICE

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Colonoscopy

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Screening or surveillance colonoscopy
2. Age 40 years or older
3. Informed consent

Exclusion Criteria

1. Emergency colonoscopies
2. Inflammatory bowel disease (IBD)
3. Colorectal Cancer (CRC)
4. Previous Colorectal Cancer (CRC)
5. Previous colonic resection
6. Returning for a planned elective therapeutic colonoscopy.
7. Polyposis syndromes (familial adenomatous polyposis)
8. Contraindication for biopsy or polypectomy.
Minimum Eligible Age

40 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Meditrial Europe Ltd.

INDUSTRY

Sponsor Role collaborator

Odin Medical

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Alessandro Repici, Prof.

Role: PRINCIPAL_INVESTIGATOR

Humanitas Research Hospital IRCCS, Rozzano-Milan

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Israeli-Georgian Medical Research Clinic Healthycore

Tbilisi, , Georgia

Site Status

Sana Klinikum Lichtenberg

Berlin, , Germany

Site Status

Humanitas Mater Domini

Castellanza, Varese, Italy

Site Status

Humanitas Catania

Catania, , Italy

Site Status

Humanitas Research Hospital

Milan, , Italy

Site Status

H-T. Centrum Medyczne

Tychy, , Poland

Site Status

The Maria Sklodowska-Curie National Research Institute of Oncology

Warsaw, , Poland

Site Status

Przychodnia Polskiej Fundacji Gastroenterologii

Warsaw, , Poland

Site Status

University Hospital "Clinico Lozano Blesa" of Zaragoza

Zaragoza, , Spain

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Georgia Germany Italy Poland Spain

Related Links

Access external resources that provide additional context or updates about the study.

https://www.meditrial.net/

Meditrial Clinical Research Organization

https://odin-vision.com/

Odin Vision Cloud Connected Endoscopy

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

RCT-2022-01

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.